Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis

Tumor necrosis factor α antagonists are increasingly used to treat inflammatory and autoimmune disorders and are associated with increased risk of active tuberculosis. Diagnosis of active tuberculosis in patients taking tumor necrosis factor α antagonists can be challenging owing to increased incide...

Descripción completa

Detalles Bibliográficos
Autores principales: Pennington, Kelly, Sasieta, Humberto C, Ramos, Guiherme P, Erskine, Courtney L, Van Keulen, Virginia P, Peikert, Tobias, Escalante, Patricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574471/
https://www.ncbi.nlm.nih.gov/pubmed/28890660
http://dx.doi.org/10.1177/1179547617724776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574471/
https://www.ncbi.nlm.nih.gov/pubmed/28890660
http://dx.doi.org/10.1177/1179547617724776

Ejemplares similares